Message-ID: <6824112.1075856467175.JavaMail.evans@thyme> Date: Fri, 8 Dec 2000 11:13:00 -0800 (PST) From: vince.kaminski@enron.com To: todd.roten@enron.com Subject: Re: Genetic Programming Cc: vince.kaminski@enron.com, pinnamaneni.krishnarao@enron.com, chonawee.supatgiat@enron.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit Bcc: vince.kaminski@enron.com, pinnamaneni.krishnarao@enron.com, chonawee.supatgiat@enron.com X-From: Vince J Kaminski X-To: Todd Van Roten X-cc: Vince J Kaminski, Pinnamaneni Krishnarao, Chonawee Supatgiat X-bcc: X-Folder: \Vincent_Kaminski_Jun2001_3\Notes Folders\Sent X-Origin: Kaminski-V X-FileName: vkamins.nsf Todd, We have several members of the group who can help you. One of them is Steve Leppard located in London. Vince To: Vince J Kaminski/HOU/ECT@ECT cc: Subject: Genetic Programming Vince- I am with the EBS Venture Capital group. We are looking at evaluating an investment in a company called Widevine out of Seattle. Part of their value proposition involves certain patents on genetic programming. Are you familiar with that? If so, can I set a meeting with you and a few other members of my group to discuss on Tuesday or Wednesday? Todd Van Roten Enron Broadband Ventures Office: (713) 853-3850 Fax: (713) 646-8010 Cell: (713) 305-0110